Smallpox is a highly contagious and virulent, often fatal infectious disease caused by variola virus, a large orthopoxvirus of the family Poxviridae, subfamily Chordopoxvirinae. The 2 classic varieties of smallpox are variola major and variola minor, each of which confers immunity against the other. Variola minor is less virulent and is found mainly in South America and West Africa. Hemorrhagic smallpox is a severe and highly fatal variety of the disease in which hemorrhages develop in the skin and mucous membranes. Flat smallpox is a severe variety in which lesions do not project above the skin surface.


Smallpox is also known as variola or variola vera. Variola minor has many synonyms and local names, such as alastrim, amaas, cottonpox, milkpox, whitepox, and Cuban itch. Smallpox is often subdivided according to clinical presentation into variola vera discreta (discrete papules) and variola vera confluens (confluent papules). Hemorrhagic smallpox, also known as fulminant smallpox, is subdivided clinically into purpura variolosa and variola pustulosa haemorrhagica (4). Malignant smallpox is another name for flat smallpox.

General Considerations

Four species of the genus Orthopoxvirus cause infection in humans: variola virus, vaccinia virus, cowpox virus, and monkeypox virus. Vaccinia virus is essentially a laboratory virus grown in chick embryos and used to vaccinate humans against smallpox (22). Cowpox virus is a virus of rodents that is transmitted to humans by cows or cats (21). In the absence of smallpox, the most important orthopoxvirus that causes human disease is monkeypox (21). Monkeys may transmit the disease to humans (7), but the major reservoirs are several species of forest squirrels. Most cases of monkeypox have been reported in forested regions of Central and West Africa (7). Monkeypox is clinically indistinguishable from smallpox, but there are significant differences between the diseases. Interhuman transmission of monkeypox is relatively poor: approximately 10% in susceptible family contacts, compared to 25% to 40% for smallpox. The mortality rate for monkeypox is substantially lower than for smallpox, and interhuman spread to a fourth generation is rare (5).

Variolation against smallpox began as early as the 10th century through intranasal insufflation of dried crusts of smallpox lesions. In 18th-century Europe, the method consisted of subcutaneous injection of fluid from smallpox pustules or scabs (23). Variolation caused a mild form of smallpox, but prevented significant morbidity and mortality. In England there was a popular concept that dairy maids who had caught cowpox were thereafter immune to smallpox. In 1796, Jenner established the validity of this folkloric concept by his discovery that subcutaneous injection of cowpox virus conferred immunity against smallpox (21,24). In 1803 the term vaccination was coined from the Latin for cow (vacca) (24). Jenner's observations also are consistent with the now recognized importance of cell-mediated immunity in resistance to smallpox. In 1967, the World Health Organization undertook a global program of smallpox vaccination. At that time, 10 to 15 million cases of the disease occurred each year, with more than 2 million deaths. The last case of endemic smallpox was reported in Somalia in 1977. In 1980, endemic smallpox was considered eradicated, vaccination ceased worldwide, and the WHO requested that all smallpox virus stocks be destroyed (6,26). The long-term consequence of eradication is that much of the world's population is now unvaccinated and at risk of infection. In the United States, routine vaccination of the civilian population ended in 1972. The most current statistics indicate that approximately 41% of the resident U.S. population is under the age of 30, most of whom have not been vaccinated against smallpox (47). The immune status of those who were vaccinated 30 or more years ago has not been satisfactorily established, but there is some evidence of residual immunity (3). Reports from the late 19th century indicate that vaccination 20 to 30 years previously may not protect against infection, but will often prevent death (20). There are no conclusive studies on whether people with residual immunity can transmit smallpox to nonvaccinated individuals (36).


Variola major has been endemic in India for at least 2000 years, and has spread to China, Japan, Africa, and the Americas (29). Beginning in the 20th century, the less virulent form of smallpox, variola minor (or alastrim), spread from South Africa to Florida and the Americas, and then to Europe (12). The mortality rate from smallpox in unvaccinated patients is 25% to 50%, and significant morbidity ranges up to 90%. Infectivity begins with the onset of rash. Virions in ulcers of the mouth and throat enter saliva and are released in oropharyngeal aerosols or droplets, the most common route of viral transmission (35). The virus can also be transmitted by contact with an infected patient or with contaminated clothing or linens (12,13,15,40). The virus can cross the placenta, but incidence of congenital smallpox is not high (39,42). Infectivity wanes in 7 to 10 days when scabs form over lesions, binding the virus in fibrin matrix (27). Incidence is highest in winter and early spring (27,34); age distribution depends on acquired immunity. Vaccination immunity declines over time and is probably lost in all but recently vaccinated populations (22).

Infectious Agent

Morphologic Description

Smallpox virus particles, or virions, are visible by light microscopy. By cryoelectron microscopy, virions appear as smooth, rounded rectangles and measure approximately 302 to 350 nm by 244 to 270 nm (17,38,48). The smallpox genome consists of a single linear double-stranded DNA molecule with a hairpin loop at each end (37), and has 186 kilobase pairs (kbp), which is 4, 6, and 34 kbp fewer than monkeypox, vaccinia, and cowpox, respectively. The DNA genome of variola minor has 2 more HindIII cleavage sites than variola major (22). Virion replication is cytoplasmic and uses viral-associated DNA-dependent RNA polymerase. Viral envelopes are made of modified Golgi membranes containing viral-specific polypeptides, including hemagglutinin. Both enveloped and nonenveloped virions are infectious (22,37).

Clinical Features and Pathogenesis

The evolution of the ordinary variety of smallpox may vary from patient to patient, depending on immune status and severity of disease. The following is an outline of the general course of disease (13,42).

Incubation Period

The incubation period lasts approximately 12 to 14 days (range: 7-21 days). During this time, virions multiply in the reticuloendothelial system. Once inhaled, variola virus invades the oropharyngeal or respiratory mucosa, migrates to regional lymph nodes, and begins to multiply. A few days later, the virus enters the bloodstream and begins a second wave of multiplication in the spleen, bone marrow, and lymph nodes. Finally, the virus reenters the blood in leukocytes, producing fever and toxemia, and then passes from leukocytes to adjacent cells in small blood vessels of the dermis and beneath the oropharyngeal mucosa.

Evolution of Rash

Preeruptive Stage

The preeruptive syndrome lasts approximately 2 to 6 days and is so typical of smallpox, it is a must for diagnosis. It is characterized by sudden onset of high fever (102� F to 105� F), prostration, encephalitis, severe headache, backache, pain in the limbs and abdomen, and sometimes vomiting. Virus is most likely to be found in the blood in the first few days of the preeruptive fever, particularly in severe infections (14).

Eruptive Stage

Day 3 or 4 of fever: Minute reddish spots appear on mucous membranes of the mouth, tongue, palate, and pharynx, and temperature falls to near normal. Mucous membranes of the lower trachea, bronchi, and lower digestive tract are affected less frequently (4).

Day 4 to 6: Rash develops on the skin 24 to 48 hours after lesions on the mucous membranes appear. Typically, macules first appear on the forehead, then rapidly spread to the whole face, proximal portions of extremities, the trunk, and lastly to distal portions of extremities. The process takes no more than 24 to 36 hours, after which no new lesions appear.

Day 6 to 8: Lesions on mucous membranes have evolved into papules and vesicles and broken down.16 Because mucous membranes lack a keratinized layer, damaged epithelial cells are shed from these lesions early in the disease, and the patient is most infective at this time (13). Macules on the skin become papules 24 to 48 hours after forming. Papules fill with an opalescent fluid to become vesicles in another 48 hours (figs. 1, 2, 3).

Day 8 to 10: Fluid in the vesicles becomes opaque, giving them the appearance of pustules; however, the so-called pustules are filled with tissue debris, not pus. There is some recurrence of fever during pustulation (figs. 4 and 5).

Day 10 to 14: Pustules mature, increase in size, and become umbilicated. Crusting begins and temperature again returns to near normal (figs. 6, 7, 8, 9, 10).

Day 16 to 20: Scab formation is complete (fig. 10).

Day 21 to 28: With the exception of those embedded in the palms of the hands and soles of the feet, most crusts have separated, leaving depigmented scars.

Hemorrhagic smallpox produces a dusky erythema, petechiae, and hemorrhages in the spleen, kidney, serosa, muscle, and, rarely, the epicardium, hepatic capsule, testes, and urinary bladder (4). Patients in the early stage of disease show a decrease in platelets, prothrombin, and accelerator globulin, and an increase in circulating antithrombin. Patients in the late stage have significant thrombocytopenia; however, deficiency of coagulation factors is less severe. Some in the late stage also show increased antithrombin (33,34). Hemorrhagic smallpox leads to certain death 5 or 6 days following the onset of rash. In the often fatal flat, or malignant, form of smallpox, confluent vesicles develop slowly, remain flat and velvety to the touch, appear fine-grained, and may cause large areas of the epidermis to slough (figs. 11 and 12) (41).

In variola minor, rash erupts more slowly, with smaller vesicles and rare umbilication or scarring. Mortality is 0.5% to 1% (11,42).

Complications and Sequelae

Complications of smallpox arise most commonly in the respiratory system and range from simple bronchitis to fatal pneumonia. Other complications include encephalitis (1 in 500 patients), which is more common in adults and may cause temporary disability; permanent pitted scars, most notably on the face; and ocular complications (2% of all cases). Pustules can form on the eyelid, conjunctiva, and cornea, leading to complications such as conjunctivitis, keratitis, corneal ulcer, iritis, iridocyclitis, and optic atropy. Blindness results in approximately 35% to 40% of eyes affected with keratitis and corneal ulcer. Hemorrhagic smallpox can cause subconjunctival and retinal hemorrhages (19,42). In 2% to 5% of young children with smallpox, virions reach the joints and bone, causing osteomyelitis variolosa. Lesions are symmetrical, most common in the elbows, tibia, and fibula, and characteristically cause separation of an epiphysis and marked periosteal reactions. Swollen joints limit movement, and arthritis may lead to ankylosis, malformed bones, flail joints, and stubby fingers (10,42).

Pathologic Features

The following survey of the histopathologic features of smallpox is based on observation of specimens submitted to the AFIP, and on several comprehensive review articles (4,9,31,49).


Capillaries in the papillary dermis dilate, the lining endothelium swells, and lymphocytes and histiocytes infiltrate the epidermis. In the middle layer of the overlying epidermis, cells enlarge, vacuolate, and degenerate (figs. 13, 14, 15, 16, 17, 18). Affected cells contain round or oval inclusion bodies, called Guarnieri's bodies, that measure 2 to 8 �m. Guarnieri's bodies are slightly basophilic or acidophilic and lie close to the nuclei in cell cytoplasm (figs. 18, 19, 20). Guarnieri's bodies are composed of viral particles and proteins; each body is the locus of viral replication and assembly. Later, viral inclusions occupy large portions of cytoplasm, especially in the base of a vesicle or pustule.

Cells proliferate in the lower epidermis and may lose normal orientation, condense, detach, hyalinize, and form the base of a vesicle. Cellular degeneration spreads in the middle layer of the epidermis. Epithelial cells that ring a vesicle proliferate, thickening the epithelium (fig. 16). The vesicle's center forms as membranes of dying cells rupture and edema increases. Septa from incompletely destroyed cells form loculations (fig. 15). Neutrophils enter vesicles and septa disappear, producing a pustule. Pustular fluid is eventually absorbed, the contents dry, and epithelial cells surrounding the pustule grow under the exudate (figs. 21 and 22). Cells flatten, are parakeratotic, and link with the adjacent unaffected keratohyalin layer. The remaining crust sheds.

Hair follicles degenerate near the epidermis, but are undamaged in deeper skin layers. Similarly, above the dermis, sweat ducts become necrotic; deeper portions of sweat glands escape damage. Sebaceous glands degenerate, necrose, and disintegrate (figs. 23 and 24). Granulation tissue leads to scarring that is most prominent on the face.

In hemorrhagic smallpox, vessels in the dermis and subpapillary network dilate and endothelium swells, producing hemorrhagic lesions in the dermis, papilla, and epidermis (figs. 25, 26, 27). Cells in the basal layer of the epidermis vacuolate and degenerate. Pustules remain in the epidermis. There are coagulation abnormalities that may contribute to the pathogenesis of hemorrhagic smallpox (43)

Respiratory and Digestive Tracts

Smallpox can affect the epithelium of the tongue (figs. 28, 29, 30), pharynx (figs. 31, 32, 33), larynx (fig. 34), trachea (figs. 35 and 36), esophagus (figs. 37, 38, 39), and appendix (figs. 40, 41, 42, 43). Necrosis begins in superficial cells, then penetrates the entire epithelium to form ulcers with neutrophils and fibrin at the base of the lesions. The trachea may have sharply defined epithelial defects 1 to 2 mm in diameter. A pseudomembrane may form in the larynx, and the laryngeal epithelium may slough. In the pharynx, patchy necrosis extends into the lamina propria. Hyperemia and edema extend into glandular ducts in the larynx and to cartilage in the trachea. Guarnieri's bodies appear in cells at the margins of necroses, and as masses rising upward in cellular debris. Lymph nodes adjacent to the pharynx, trachea, tonsils, and thymus are focally necrotic (fig. 44).


In comatose patients, aspirated food or detached pseudomembranes from proximal airways can cause bronchopneumonia, with accompanying abscess formation and bacterial growth. Bronchiolar epithelial cells become mitotic and pseudostratified (fig. 45). Alveolar lining cells are swollen, mitotic, or degenerating, with karyorrhexis and karyolysis. Alveolar spaces are edematous and contain erythrocytes and, often, detached alveolar lining cells (figs. 46, 47, 48, 49, 50, 51, 52).


Cardiac involvement in smallpox is infrequent but can include hyperemia and small hemorrhages. Large mononuclear cells may pack subendocardial capillaries. Capillary endothelial cell hyperplasia and subsequent perivascular lymphocytes, macrophages, eosinophils, and interfibrillar edema may affect cardiac capillaries and adjacent tissues (figs. 53 and 54).


Hepatic cell nuclei vary in size, with occasional multiple nuclei, mitosis, or individual cell necrosis (apoptotic cells or Councilman's bodies) (figs. 55, 56, 57). Endothelial cells lining sinusoids become swollen and necrotic. Large mononuclear cells with round nuclei and prominent chromatin fill sinusoids. Lymphocytes and occasional plasma cells, eosinophils, and large mononuclear cells occupy the hepatic triads. Foci of coagulation necrosis are more common in the area adjacent to the hepatic triads. Central veins and sinusoids are engorged and there are focal hemorrhages.


The spleen is enlarged and engorged and there are small hemorrhages in the red and white pulp. Sinuses are engorged with blood and prominent endothelial cells line the widened sinuses. Follicles are hyperplastic and numerous reticulum cells are actively mitotic. Lymphocytes, large mononuclear cells, and eosinophils infiltrate the trabeculae. There are few neutrophils (figs. 58, 59, 60). Peritoneal mesothelial cells contain Guarnieri's bodies.


Pathologic changes in the kidney are most prominent in the medulla. The interstitium is edematous and infiltrated by lymphocytes, plasma cells, eosinophils, and mononuclear cells. Tubular epithelial cells are swollen, degenerated, or mitotic. Congestion and hemorrhage may extend into the renal pelvis and ureter (fig. 61).


Foci of necrosis 1 to 3 mm in diameter form in the testes, with focal hyperemia and hemorrhage. Plasma cells, reticuloendothelial cells, and eosinophils infiltrate the interstitium, and mononuclear cells accumulate in vessels. Tubules are initially unaffected but subsequently degenerate, with necrosis extending to the interstitium. In adults, proximal blood vessels thrombose; in juveniles, foci of necrosis resemble ischemic infarction (figs. 62 and 63).

Bone Marrow

Occasional necrosis and small hemorrhages are seen in bone marrow. Reticulum cells are hyperplastic with nuclear degeneration. Some patients lose megakaryocytes.

Adrenal Glands

The adrenal cortex is hyperemic; the adrenal medulla is hyperemic and has small hemorrhages. Lymphocytes and plasma cells infiltrate small vessels and sinusoids.

Soft Tissue

Punctate hemorrhages form in serous membranes, muscle, and fascia.


Lymphocytes and plasma cells infiltrate around arteries and veins of the brain and spinal cord in layers 1 to 4 cells deep. Perivascular demyelinization with infiltrating microglia extends outward from affected vessels. Perivascular lesions are focally prominent in the cortex and white matter of the cerebral hemispheres, brain stem, and spinal cord. Lymphocytes also infiltrate meninges (8,32)


To collect specimens, use forceps to pick off a scab, the blunt edge of a scalpel to open vesicles or pustules, and a cotton swab to absorb the fluid. Deposit specimens in a blood collection test tube with a rubber stopper, seal the stopper with adhesive tape, and enclose the tube in a watertight container. Contact state or local health department laboratories regarding proper shipping of specimens. Specimens should be collected only by a vaccinated individual wearing latex gloves and a surgical mask. Laboratory examination must be performed in a biosafety level 4 facility (27).

All orthopoxviruses exhibit identical brick-shaped virions by electron microscopy. Definitive laboratory identification of variola virus involves growing the virus in cell culture or on chorioallantoic egg membrane44 and characterizing strains by PCR techniques45 or restriction fragment-length polymorphisms. Once a smallpox epidemic is established, clinically typical cases should not require laboratory confirmation.

Neutralizing and hemagglutinin-inhibiting antibodies appear on day 6 of rash (day 21 of infection), and complement-fixing antibodies on day 23 of infection. Complement-fixing antibodies fade in 6 months, hemagglutinin-inhibiting antibodies in 5 years, and neutralizing antibodies in 10 years (23).

Smallpox as Biowarfare Agent


The Europeans who colonized North America in the 17th and 18th centuries were well aware of the devastating effects of smallpox among Native American tribes. On several occasions, the colonists made deliberate attempts to infect Native Americans, essentially using smallpox as a weapon in the war for territory. One of the best known instances took place during the French and Indian Wars (1754-1767), when British forces distributed blankets contaminated with variola among groups of Native Americans. There is no record of the outcome of this particular experiment, but by the time of the American Revolution, smallpox had wiped out entire tribes and decimated many more.18

In 1947, the first bioweapons laboratory in the former Soviet Union grew variola virus in embryonic chicken eggs.2 The weaponized liquid egg material remained viable for a year following mixture, stabilization, and refrigeration. In 1967, the Russian laboratory isolated a more virulent strain of smallpox from India that, when aerosolized, produced symptoms in monkeys within 1 to 5 days. The virus was later adapted for delivery in bombs and intercontinental ballistic missiles.

The genetic structure of vaccinia virus is almost identical to variola major. In 1990, using vaccinia as a surrogate in smallpox weapons research, Soviet scientists successfully inserted a DNA copy of Venezuelan equine encephalomyelitis into vaccinia virus. In 1997 the same Russian team inserted the gene for Ebola into the vaccinia genome. Today, according to official reports, biowarfare research in Russia and the former Soviet states has ceased and stockpiles of variola virus have been destroyed.1 But political and financial disruptions in the region during the 1990s have led to speculation as to the security and whereabouts of information and material concerning biological agents (25).


Aerosol release of variola virus by terrorist organizations is an increasingly real threat to the civilian population, most of whom are either unvaccinated or have lost immunity. Should such an attack take place, early detection would be essential to an effective defense. An epidemic could be controlled if sufficient vaccine (at least 40 million doses) were available in the first 4 to 8 weeks following an attack.

Treatment and Prevention

There is no effective antiviral treatment for smallpox. Patients suspected of smallpox infection should be isolated and given supportive therapy and antibiotics for secondary bacterial infections. All household members and close contacts should wear protective clothing, including gloves, gowns, and masks, and should be vaccinated and put under surveillance. All laundry and waste should be placed in biohazard bags and autoclaved, laundered in hot water and chlorine bleach, or incinerated. Standard hospital disinfectants such as hypochlorite and quaternary ammonia should be used to clean surfaces that may be contaminated with virus (27). For patients with hemorrhagic smallpox, therapy with platelet-rich fresh, frozen, or freeze-dried plasma may be of some benefit (33). Only 3% of vaccinated contacts develop smallpox, compared with almost 40% of unvaccinated contacts (42). Vaccination within 4 days of first exposure offers moderate protection against acquiring infection and significant protection against a fatal outcome (12). The United States has a stockpile of smallpox vaccine consisting of virus grown on scarified calves in the 1970s. Those receiving vaccine should be informed that rare complications can result from vaccination, such as postvaccination encephalitis, vaccinia gangrenosa in patients with T-cell immunodeficiencies, eczema vaccinatum in patients with atopic dermatitis, generalized vaccinia, and erythematous urticarial lesions (28). The United States has a small supply of vaccinia immunoglobulin, which may be given in conjunction with smallpox vaccine to individuals at risk of vaccine-related complications (46), those with severe cutaneous reactions to vaccination(30), and immunocompromised individuals or those for whom vaccination is otherwise contraindicated.

This Web presentation is a product of the Armed Forces Institute of Pathology, with contributions from the following members of the AFIP:

Department of Infectious and Parasitic Diseases Pathology
Douglas J. Wear, MD
Mary K. Klassen-Fischer, MAJ, MC, USA
Peter L. McEvoy, COL, MC, USA
Wayne M. Meyers, MD, PhD
Ann M. Nelson, MD
Ronald C. Neafie, MS
Jos� Rodriguez, AA
Cindy Wilson

Center for Scientific Publications
Bonnie L. Casey, MA
Michele Richman, BA

Department of Dermatopathology
Sylvana M. Tuur-Saunders, MD
Wendy Lee, LCDR, MC, USN

Department of Endocrine & Otorhinolaryngic/Head-Neck Pathology
Lester D.R. Thompson, MD

Department of Neuropathology
Hernando Mena, COL, MC, USA

Division of Visual Information
Anthony E. Shirley, BS

The views of the authors and editors do not purport to reflect the positions of the Departments of the Army, Navy, or Defense.